Suboptimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena.

MLA

Mukherjee, Manali, et al. “Suboptimal Treatment Response to Anti-IL-5 Monoclonal Antibodies in Severe Eosinophilic Asthmatics with Airway Autoimmune Phenomena.” The European Respiratory Journal, vol. 56, no. 4, Oct. 2020. EBSCOhost, https://doi.org/10.1183/13993003.00117-2020.

APA

Mukherjee, M., Forero, D. F., Tran, S., Boulay, M.-E., Bertrand, M., Bhalla, A., Cherukat, J., Al-Hayyan, H., Ayoub, A., Revill, S. D., Javkar, T., Radford, K., Kjarsgaard, M., Huang, C., Dvorkin-Gheva, A., Ask, K., Olivenstein, R., Dendukuri, N., Lemiere, C., … Nair, P. (2020). Suboptimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena. The European Respiratory Journal, 56(4). https://doi.org/10.1183/13993003.00117-2020

Chicago

Mukherjee, Manali, David Felipe Forero, Stephanie Tran, Marie-Eve Boulay, Mylène Bertrand, Anurag Bhalla, Jayant Cherukat, et al. 2020. “Suboptimal Treatment Response to Anti-IL-5 Monoclonal Antibodies in Severe Eosinophilic Asthmatics with Airway Autoimmune Phenomena.” The European Respiratory Journal 56 (4). doi:10.1183/13993003.00117-2020.